Skip to content

Clinical Implications of Venous Excess Ultrasound (VExUS) and Lung ultrasound (LUS) to predict Outcomes During Fluid Removal in Critically Ill Patients: a prospective observational study

Clinical Implications of Venous Excess Ultrasound (VExUS) and Lung ultrasound (LUS) to predict Outcomes During Fluid Removal in Critically Ill Patients: a prospective observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20250420003
Enrollment
41
Registered
2025-04-20
Start date
2024-10-30
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

VExUS and LUS score change in critically ill patients with fluid overload undergoing fluid removal therapy fluid overload

Interventions

Adult patients aged 18 years old or older who admitted to the medical intensive care unit and required fluid removal
Diagnostic
Critical ills with fluid overload

Sponsors

Faculty of Medicine Siriraj Hospital , Mahidol University ,Thailand
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Adult patients aged 18 years old or older who admitted to the medical intensive care unit and are expected to remain in the ICU for over 120 hours. 2) The patient had stable vital signs without the need for rapid fluid resuscitation (at least 500 milliliters of colloid or 1000 milliliters of crystalloid) or with minimal vasoactive medications (e.g., norepinephrine at a rate not exceeding 0.1 micrograms per kilogram per minute and dobutamine at a rate not exceeding 10 micrograms per kilogram per minute) for a consecutive period of 12 hours. 3) The patients require fluid removal determined by the attending physicians and involved the use of either diuretics or renal replacement therapy.

Exclusion criteria

Exclusion criteria: 1) Underlying chronic kidney disease stage 4 or higher, or those undergoing chronic dialysis, such as intermittent hemodialysis or peritoneal dialysis 2) Decompensated cirrhosis with portal hypertension 3) History of IVC, PV, HV, or renal vein thrombosis 4) Ureteral obstruction 5) Intraabdominal hypertension (intraabdominal pressure > 12 mmHg) 6) Pregnant women 7) Transplanted kidney or transplanted liver patients 8) Patients with do-not-resuscitate orders or decisions to withhold life-sustaining treatments 9) Patients or their legally authorized representatives decline to participate 10) Inadequate POCUS image quality, such as the inability to assess the Doppler ultrasonography view

Design outcomes

Primary

MeasureTime frame
Ventilator-free days 28 days after the enrollment days / days from the end of mechanical ventilation to day 28. If a patient dies within the first 28 days, their VFD count is zero.

Secondary

MeasureTime frame
Mortality 28 days after the enrollment categorical data,VExUS score 3 days after the enrollment 0-3 / categorical data,LUS score 3 days after the enrollment 0 to 32 / continuous data,Length of ICU stay until discharge from ICU days / continuous data,Cumulative fluid balance 3 days after the enrollment liters / continuous data

Countries

Thailand

Contacts

Public ContactRanistha Ratanarat

Faculty of Medicine Siriraj Hospital, Mahidol University

ranittha@gmail.com006624198534

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026